Skip to content
Screener

Roivant Sciences ROIV Research and development expenses

Research and development expenses at other companies

Mineralys Therapeutics, Inc. logo
Mineralys Therapeutics, Inc.MLYS
$4.59M-52.5%
Vir Biotechnology, Inc. logo
Vir Biotechnology, Inc.VIR
$35.47M-9.8%
Vir Biotechnology, Inc. logo
Vir Biotechnology, Inc.VIR
$35.47M-9.8%
Titan International logo
Titan InternationalTWI
$1.01M+13.3%
Titan International logo
Titan InternationalTWI
$1.49M+9.7%
Baxter International logo
Baxter InternationalBAX
$22M-15.4%

Other financials

Income statement

See full
Revenue$1.4M-33.5%
Operating income-$366.0M-28.5%
Net income-$189.8M+15.0%
EPS (diluted)-$0.26+21.2%

Balance sheet

See full
Cash & equivalents$77.1M-18.7%
Total debt$107.2M+7.5%
Total equity$4.2B-2.6%
Total assets$5.3B+5.4%

Cash flow

See full
Operating cash flow-$270.5M-32.4%
CapEx$419.0K-89.6%
Free cash flow-$270.9M-30.0%

Valuation

See full
Market cap$25B+214%
Enterprise value$25.03B+215%
P/S3,318.5×+2,976×

Profitability

See full
Operating margin-9,130.5%-13,995pp
Net margin-6,079.9%-6,193pp
FCF margin-10,901%-22,382pp

Returns & leverage

See full
Return on equity-17.1%-17.7pp
Debt / equity0×0.0×
Current ratio16.7×-23.8×

Where this comes from

Reported directly by Roivant Sciences in its filing.

Tagged under the XBRL concept roiv:AccruedResearchAndDevelopmentExpensesCurrent.

The source filing: Roivant Sciences’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 7:28 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q2 2026
Accession
0001635088-26-000090
Line itemJune 30, 2026March 31, 2026
Research and development expenses$113,438$92,749
Compensation-related expenses40,82087,325
Other expenses14,48225,749
Total accrued expenses$168,740$205,823

Item 1. Financial Statements (Unaudited).

FAQ

What is Roivant Sciences's research and development expenses?
Roivant Sciences (ROIV) reported research and development expenses of $113.44M in Q2 2026.
How has Roivant Sciences's research and development expenses changed year-over-year?
Roivant Sciences's research and development expenses increased by 127.8% year-over-year, from $49.8M to $113.44M.
What is the long-term trend for Roivant Sciences's research and development expenses?
Over 4 years (2021 to 2025), Roivant Sciences's research and development expenses has grown at a 8.8% compound annual growth rate (CAGR), from $66.19M to $92.75M.
What does research and development expenses mean?
Research and development expenses as reported by Roivant Sciences Ltd. Common Shares.

Ask your AI about Roivant Sciences's research and development expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude